logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    
Gilead Sciences Inc.

Gilead Sciences Inc. (GILD)

Follow

Details

Wall

Profile


Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.

Issuer Information

Exchange: NASDAQ
Market Cap: 85694490248
CEO: John C. Martin
Employees: 5000
Issuer Type: CS
Auditor: Ernst & Young LLP
Last Audit: UQ
CIK: 882095
Sector: Healthcare
Industry: Biotechnology
Sub-Industry: Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturin (325414)
SIC: 2836
Last earning call url:
Slideshare slide url:

Contact Information

Main phone: +1 650 574-3000
Address: 333 Lakeside Drive
Address 2:
State: CA
City / Town: Foster City
Country: USA
Postal Code: 94404
Fax:

Videos

No public videos available.

Blog

No Result Found.

News

Stock in TG Therapeutics (TGTX) popped in Wednesday trading, seeing shares bounce 9.11%. Driving the gains appears to be the favorable deal secured by rival Infinity (INFI) with AbbVie (ABBV)…
For over four decades, Guild Investment Management and its founder Monty Guild have deployed a proven investing strategy, scanning for opportunities in both the U.S. and international markets. The key…
In the U.S. alone, some 3.2 million people have chronic hepatitis C virus. Between 75% and 85% of people infected with hepatitis C virus develop chronic infection. According to data…
A biotech analyst could play it safe, and stick with mid-, late- and commercial-stage companies that offer higher odds and decent returns on good news. Christopher James, on the other…
Aging baby boomers face increased cancer risk, and growing numbers of obese and overweight Americans face metabolic disorders that could lead to cardiovascular disease. Debjit Chattopadhyay of ROTH Capital Partners…
Gilead Sciences Inc. (GILD) posted Q2 2014 earnings of $2.36 a share, easily beating the consensus estimate by 58 cents.Sales came in at $6.53 billion, topping earlier estimate by 12%.…
If investors were as practical with their investment portfolio as they are with managing a garden, they might make a lot more money! There are so many analogies between managing…
The biotech bull market is not over. That's the judgment of Reni Benjamin of H.C. Wainwright & Co., who predicts high quality data from a broad range of small- and…
GlobeImmune  (GBIM)  is a biopharmaceutical company established in 1995 focused on developing products for the treatment of cancer and infectious diseases based on its proprietary Tarmogen® platform. It is headquartered…
“The Captain has suggested you wear your safely belt…time to be cautious.” We have had a tremendous ride with the stock market for an extended period of time. Since the…

Trending

Social Mentions about your company in the last seven days
Keith Lovell
30 Sep 14 06:51:08
Daily shake n' bake plus EOQ window dressing - stay focused, ignore the noise $GILD $WLL $CELG
Quantpost Healthcare
30 Sep 14 06:50:58
$GILD News Alert: http://t.co/vKXQhtaZwO Updated options view: https://t.co/9mjbuvYfXg All options views: https://t.co/fArdRSxADp
Seeking Alpha
30 Sep 14 06:50:43
4 Predictions For The Fourth Quarter http://t.co/TyzvCrcKRk $GILD $F $SPY $DIA $QQQ $IWM
FierceBiotech
30 Sep 14 06:49:31
J&J makes a splash in hep C with a $1.75B deal for Alios. http://t.co/uWek8JXXFj by @DamianFierce $JNJ $GILD $ABBV
Scott Spencer
30 Sep 14 06:36:00
$CPRX +12% $3.37 Catalyst trying to pull the $GILD schtick on American patients... http://t.co/WH0GJQYuLx
FinGraphs
30 Sep 14 06:34:01
RT @fgusequity: $GILD Potential continuation Uptrend on an Investor's View : W-D-Hourly charts http://t.co/noUe1Hf6Yi
FinGraphs US Equity
30 Sep 14 06:33:58
$GILD Potential continuation Uptrend on an Investor's View : W-D-Hourly charts http://t.co/noUe1Hf6Yi
ISAAC ALEX
30 Sep 14 06:17:54
RT @megtirrell: $MRK 4-wk HCV regimen may not have sufficient efficacy for approval, DB says. Notes FDA may be looking for 95%+ cure rate $…
The MOAT
30 Sep 14 06:16:48
RT @dougheuringaria: DB take on HCV pricing & shorter duration after speaking w/ mgmt $mrk $gild http://t.co/ICoLmRNkpQ
The MOAT
30 Sep 14 06:16:43
RT @megtirrell: $MRK 4-wk HCV regimen may not have sufficient efficacy for approval, DB says. Notes FDA may be looking for 95%+ cure rate $…
Joe Arena
30 Sep 14 06:06:41
RT @dougheuringaria: DB take on HCV pricing & shorter duration after speaking w/ mgmt $mrk $gild http://t.co/ICoLmRNkpQ
Beck
30 Sep 14 06:04:12
RT @Lin_ling_88: France uses tax to put pressure on #HCV drug price $gild $mrk $abbv http:http://t.co/VbctrbO1lc
Seamus
30 Sep 14 06:03:17
RT @dougheuringaria: DB take on HCV pricing & shorter duration after speaking w/ mgmt $mrk $gild http://t.co/ICoLmRNkpQ
Joe
30 Sep 14 06:02:47
RT @dougheuringaria: DB take on HCV pricing & shorter duration after speaking w/ mgmt $mrk $gild http://t.co/ICoLmRNkpQ
Patrick
30 Sep 14 06:00:04
#SENTISHIFTUP $NXTD $GILD $AA $NWS $GOOG $TSLA $SPX $JNJ $AMZN $NFLX #quantheta
biotech 2050
30 Sep 14 05:54:01
RT @dougheuringaria: DB take on HCV pricing & shorter duration after speaking w/ mgmt $mrk $gild http://t.co/ICoLmRNkpQ
dougheuring
30 Sep 14 05:52:40
DB take on HCV pricing & shorter duration after speaking w/ mgmt $mrk $gild http://t.co/ICoLmRNkpQ
Helen Ong
30 Sep 14 05:49:26
France uses tax to put pressure on #HCV drug price $gild $mrk $abbv http:http://t.co/VbctrbO1lc
ArizonaTrader
30 Sep 14 05:47:33
Adv/Dec & New High Lows and # of dist days in $COMPQ and $SPX keep me from buying but still holding $FB and $GILD http://t.co/yjVuJudIsh
Argiris Papafragkou
30 Sep 14 05:30:35
RT @megtirrell: $MRK 4-wk HCV regimen may not have sufficient efficacy for approval, DB says. Notes FDA may be looking for 95%+ cure rate $…
Ben Hirschler
30 Sep 14 05:24:31
Interesting approach -> #France uses tax to put pressure on #hepatitis C drug prices http://t.co/iSztoA5Go2 $GILD #pharma
Joe Leonard
30 Sep 14 05:24:27
S&P Gems - 31.2% 1 YR vs 20.1% $SPY . Largest holdings are $MU $GILD $ACT and $LRCX http://t.co/dDgmlaALf5
Joe Leonard
30 Sep 14 05:22:13
S&P Gems - 31.2% 1 YR vs 20.1% $SPY . Largest holdings are $MU $GILD $ACT and $LRCX
Helen Ong
30 Sep 14 04:59:22
@megtirrell $GILD execs said this repeatedly at recent analysts mtgs. 95% SVR12 minimum req by FDA. Bar is a lot higher4 HCV than a year ago
Helen Ong
30 Sep 14 04:43:03
RT @megtirrell: $MRK 4-wk HCV regimen may not have sufficient efficacy for approval, DB says. Notes FDA may be looking for 95%+ cure rate $…
jjz
30 Sep 14 04:42:47
RT @megtirrell: $MRK 4-wk HCV regimen may not have sufficient efficacy for approval, DB says. Notes FDA may be looking for 95%+ cure rate $…
Ismar Karadzic
30 Sep 14 04:39:20
RT @megtirrell: $MRK 4-wk HCV regimen may not have sufficient efficacy for approval, DB says. Notes FDA may be looking for 95%+ cure rate $…
Ismar Karadzic
30 Sep 14 04:36:33
$MRK 4-wk HCV regimen may not have sufficient efficacy for approval, DB says. Notes FDA may be looking for 95%+ cure rate $GILD @sdfederman
biotech 2050
30 Sep 14 04:32:26
RT @megtirrell: $MRK 4-wk HCV regimen may not have sufficient efficacy for approval, DB says. Notes FDA may be looking for 95%+ cure rate $…
RNA_Biotech
30 Sep 14 04:29:50
RT @megtirrell: $MRK 4-wk HCV regimen may not have sufficient efficacy for approval, DB says. Notes FDA may be looking for 95%+ cure rate $…
Meg Tirrell
30 Sep 14 04:29:09
$MRK 4-wk HCV regimen may not have sufficient efficacy for approval, DB says. Notes FDA may be looking for 95%+ cure rate $GILD
Tyler
30 Sep 14 04:28:10
I always said uh oh when Congress figures out Sovaldi IP situation http://t.co/Z9tX20xvFP $GILD
Daytradeya
30 Sep 14 04:09:43
RT @IBDinvestors: These stocks helped vault the biotech group to No. 4 from 72 out of 197 in just 3 weeks http://t.co/vCo9u78oEW $GILD http…
gil43
30 Sep 14 03:16:13
RT @Sachakin: Intercept $ICPT citée comme cible d'acquisition potentielle (notamment par Gilead $GILD).. $GNFT http://t.co/noBs9wKDYm
12Stocks.com
30 Sep 14 03:01:18
Weekly S&P100 #Stocks Performance $NKE $FB $FDX $MCD $GILD $SLB $MO $HAL $LMT $HD $DOW $SBUX $ACN $DD $APC more@ http://t.co/n4QZIDxy7w
Jason Holman
30 Sep 14 02:56:33
$MGNX Secured large partner expansion http://t.co/m9JZHW4Ls1 $GILD $ABLX $BIND $PCYC $MSTX $XOMA $AFMD Making 1last tweak to bios for 4Q'14.
Gotham City Capital
30 Sep 14 02:34:57
RT @wcclubchamp: @TravisMKnight will look into it! Structured around HCV, HBV, NASH, & immuno oncology. Liver & IO: $ACHN, $GILD, $INCY, $A…
Caren Vinaixa
30 Sep 14 02:33:34
RT @HenryEChang: #Spain negotiated €25,000 per tx for #Sovaldi or 45% less of #UK cost (£35,000) with 4x more #HCV pts (900,000) than UK (2…
Gotham City Capital
30 Sep 14 01:43:35
@wcclubchamp Yes.. $GILD def the leader and could very well stay on top.. You are right on my friend.. No disagreement there..
Carine
30 Sep 14 01:41:18
RT @Sachakin: Intercept $ICPT citée comme cible d'acquisition potentielle (notamment par Gilead $GILD).. $GNFT http://t.co/noBs9wKDYm
Wcclubchamp
30 Sep 14 01:25:38
@TravisMKnight will look into it! Structured around HCV, HBV, NASH, & immuno oncology. Liver & IO: $ACHN, $GILD, $INCY, $ARWR, $MGNX, $CLDX
Daniel De Oliveira
30 Sep 14 01:12:33
RT @Sachakin: Intercept $ICPT citée comme cible d'acquisition potentielle (notamment par Gilead $GILD).. $GNFT http://t.co/noBs9wKDYm
rolly
30 Sep 14 00:53:58
$AGIO, $AKRX, $AGN, $ALNY, $ANAC, $LOCO, $GILD, $HBI, $HNT, $ICLR, $INSY, $LRCX, $MCK, $MU, $MBLY, $NTCT, $PANW, $SWKS, $SPB, $SNCR, $XRS
Stockaholics
30 Sep 14 00:04:56
$VOIS gained 218.52% in less than 3 weeks, after our Penny Stock Alerts! Major Update: http://t.co/HglCNdSVSO $GILD $NWSA $EBAY
Christine Livoti
29 Sep 14 22:56:26
RT @dougheuringaria: Major competitors in the all-oral race $gild $mrk $achn $enta http://t.co/vxzJZvVQja
jatinam
29 Sep 14 22:47:38
RT @IBDinvestors: These stocks helped vault the biotech group to No. 4 from 72 out of 197 in just 3 weeks http://t.co/vCo9u78oEW $GILD http…
4-traders.com
29 Sep 14 22:45:19
Gilead Sciences : Submits NDA to Japan's PMDA for Fixed-Dose Combination of Ledipasvir/Sofosbuvir for Chron... http://t.co/jDYpowIUyD $GILD
Christian Tharp, CMT
29 Sep 14 22:37:22
$GILD, $AMGN, $CELG, just to name a few.... http://t.co/36TNniN5bF
Major Pharma Feed
29 Sep 14 21:46:48
Biotech Stocks Rebound On Strong Earnings, New... $gild $regn $celg $alxn $biib $uthr $sny http://t.co/MRPU2ACLwg http://t.co/0SIWJBJU0d
Fraser Mackie Ltd
29 Sep 14 21:46:41
RT @IBDinvestors: These stocks helped vault the biotech group to No. 4 from 72 out of 197 in just 3 weeks http://t.co/vCo9u78oEW $GILD http…

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.